Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Eldecalcitol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104711313A details enzymatic resolution for eldecalcitol intermediates. This method ensures high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104830943A reveals enzymatic resolution for high-purity eldecalcitol intermediate, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturers.
Novel 3-step synthesis of Eldecalcitol 20S isomer via silyl protection and coupling. Offers high yield over 65 percent and cost-effective scale-up for pharmaceutical impurity standards.
Patent CN107245045A boosts eldecalcitol coupling yield to 49%, cutting costs and ensuring reliable high-purity API intermediate supply chains.